SCHEMBL13970263

SCHEMBL13970263

O/[N+](=C\c1ccccc1)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.41
▸ MAPT P10636 4/20 0.41
▸ G6PD P11413 2/20 0.41
▸ TSHR P16473 2/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ RECQL P46063 1/20 0.41
▸ NPC1 O15118 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ POLB P06746 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ TDP1 Q9NUW8 2/20 0.36
▸ MAOB P27338 1/20 0.36
▸ CYP2A6 P11509 1/20 0.36
▸ NFE2L2 Q16236 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ HDAC3 O15379 1/20 0.34
▸ TNKS O95271 1/20 0.34
▸ HDAC4 P56524 1/20 0.34
▸ HDAC1 Q13547 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19217996 1.00 ALDH1A1 (0.41) ALDH1A1MAPTG6PDTSHRALOX15
SCHEMBL19788483 0.82 ALDH1A1 (0.48) ALDH1A1TSHRPOLBTDP1L3MBTL1
SCHEMBL12411092 0.73 NPC1 (0.60) ALDH1A1MAPTRECQLNPC1RAB9A
SCHEMBL18040865 0.72 G6PD (0.47) ALDH1A1MAPTG6PDTSHRALOX15
SCHEMBL17689681 0.72 TDP1 (0.41) ALDH1A1MAPTG6PDTSHRALOX15
SCHEMBL264278 0.70 ALDH1A1 (0.73) ALDH1A1MAPTG6PDTSHRALOX15
SCHEMBL264277 0.70 ALDH1A1 (0.73) ALDH1A1MAPTG6PDTSHRALOX15
SCHEMBL12349218 0.70 ALDH1A1 (0.73) ALDH1A1MAPTG6PDTSHRALOX15
SCHEMBL19465175 0.70 TRPA1 (0.38) ALDH1A1MAPTG6PDTSHRALOX15
SCHEMBL7399649 0.69 TAAR1 (0.33) ALDH1A1MAPTG6PDTSHRALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090018343-A1 Fluorous Oxazolidinone Chiral Auxiliary Compounds and Methods of Manufacture THE UNIVERSITY OF MANITOBA (CA) 2009-01-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090018343-A1 Fluorous Oxazolidinone Chiral Auxiliary Compounds and Methods of Manufacture AFF2, FPR2, PFAS ALDH1A1 2207/4885MAPT 4872/4885G6PD 2949/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback